Hydrochloric Acid

Hydrochloric Acid

SCHEMBL3928802

CC([n+]1ccc(-c2cc[n+](C(c3ccccc3)P(=O)(O)O)cc2)cc1)P(=O)(O)O.[Cl-].[Cl-]

nearest known ligand 0.41

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
▸ ACP3 P15309 13/20 0.41
▸ SRC P12931 1/20 0.40
▸ MMP8 P22894 1/20 0.36
▸ MMP14 P50281 1/20 0.36
▸ CA14 Q9ULX7 1/20 0.36
▸ ANPEP P15144 1/20 0.35
▸ ALDH1A1 P00352 2/20 0.34
▸ LMNA P02545 2/20 0.34
▸ HTT P42858 2/20 0.34
▸ SMN1; SMN2 Q16637 2/20 0.34
▸ KDM4E B2RXH2 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL1227055 0.84 ACP3 (0.34) ACP3SRCMMP8MMP14CA14
Hydrochloric Acid SCHEMBL2264057 0.82 ACP3 (0.41) ACP3SRCMMP8MMP14CA14
SCHEMBL1226946 0.82 ACP3 (0.35) ACP3SRCMMP8MMP14CA14
Bromide SCHEMBL1227449 0.81 LMNA (0.36) ACP3SRCMMP8MMP14CA14
Hydrochloric Acid SCHEMBL2259521 0.80 ACP3 (0.40) ACP3SRCMMP8MMP14CA14
Hydrochloric Acid SCHEMBL2259577 0.80 ACP3 (0.38) ACP3SRCMMP8MMP14CA14
Hydrochloric Acid SCHEMBL2899630 0.80 ACP3 (0.43) ACP3SRCMMP8MMP14CA14
Hydrochloric Acid SCHEMBL2260159 0.79 ALDH1A1 (0.49) ACP3ALDH1A1LMNAHTTSMN1; SMN2
Hydrochloric Acid SCHEMBL2892897 0.79 ACP3 (0.39) ACP3SRCMMP8MMP14CA14
Hydrochloric Acid SCHEMBL2259031 0.78 ACP3 (0.39) ACP3SRCMMP8MMP14CA14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090259042-A1 ELECTROCHROMIC COMPOUNDS NTERA LIMITED (IE) 2009-10-15 — — US disclosed
US-7567371-B2 Electrochromic compounds NTERA LIMITED (IE) 2009-07-28 — — US disclosed
US-20060110638-A1 Electrochromic compounds NTERA LIMITED (IE) 2006-05-25 — — US disclosed
EP-1594938-A1 ELECTROCHROMIC COMPOUNDS Ntera Limited (IE) 2005-11-16 — — EP disclosed
WO-2004067673-A1 ELECTROCHROMIC COMPOUNDS NTERA LIMITED (IE) 2004-08-12 — — WO disclosed
EP-1443091-A1 Electrochromic compounds Ntera Limited (IE) 2004-08-04 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090259042-A1 ELECTROCHROMIC COMPOUNDS ETV6, HCN2, EED ACP3 2868/4885SRC 2252/4885MMP8 2139/4885
US-20060110638-A1 Electrochromic compounds ETV6, HCN2, EED ACP3 2868/4885SRC 2252/4885MMP8 2139/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback